ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E20.92 EPS (ttm)4.81 Insider Own0.50% Shs Outstand1.75B Perf Week-3.19%
Market Cap177.00B Forward P/E21.49 EPS next Y4.69 Insider Trans-3.08% Shs Float1.74B Perf Month-4.51%
Income8.55B PEG1.90 EPS next Q0.93 Inst Own75.80% Short Float0.74% Perf Quarter-8.01%
Sales45.55B P/S3.89 EPS this Y57.00% Inst Trans0.37% Short Ratio2.76 Perf Half Y-14.55%
Book/sh20.81 P/B4.84 EPS next Y-7.01% ROA11.50% Target Price124.94 Perf Year-19.65%
Cash/sh5.28 P/C19.05 EPS next 5Y11.00% ROE24.10% 52W Range98.81 - 142.60 Perf YTD-28.46%
Dividend1.88 P/FCF33.98 EPS past 5Y40.70% ROI13.50% 52W High-29.77% Beta0.71
Dividend %1.87% Quick Ratio1.50 Sales past 5Y15.60% Gross Margin58.10% 52W Low1.35% ATR2.26
Employees113000 Current Ratio2.00 Sales Q/Q10.10% Oper. Margin22.40% RSI (14)34.56 Volatility2.19% 2.14%
OptionableYes Debt/Eq0.46 EPS Q/Q72.40% Profit Margin18.80% Rel Volume0.86 Prev Close100.68
ShortableYes LT Debt/Eq0.46 EarningsJul 20 BMO Payout38.00% Avg Volume4.69M Price100.14
Recom2.00 SMA20-3.59% SMA50-6.47% SMA200-14.36% Volume3,030,311 Change-0.53%
Jul-06-22Initiated Wolfe Research Underperform $95
Mar-02-22Resumed BofA Securities Buy $140
Jan-27-22Reiterated UBS Buy $138 → $142
Jan-27-22Reiterated Raymond James Outperform $150 → $143
Jan-27-22Reiterated Morgan Stanley Overweight $157 → $151
Jan-27-22Reiterated Credit Suisse Outperform $138 → $139
Dec-10-21Initiated RBC Capital Mkts Outperform $146
Oct-27-21Upgrade Atlantic Equities Neutral → Overweight $144
Oct-14-21Initiated Redburn Neutral
May-25-21Initiated Barclays Overweight $150
Apr-15-21Initiated Atlantic Equities Neutral $122
Jan-28-21Upgrade BTIG Research Neutral → Buy $140
Sep-11-20Initiated Wolfe Research Outperform $124
Jun-01-20Downgrade Goldman Neutral → Sell $84
Mar-05-20Initiated Citigroup Buy $96
Feb-13-20Initiated Goldman Neutral $96
Feb-06-20Resumed BTIG Research Neutral
Jan-02-20Downgrade Guggenheim Buy → Neutral
Jun-13-19Reiterated BofA/Merrill Buy $81 → $90
Feb-07-19Reiterated BofA/Merrill Buy $73 → $81
Sep-26-22 10:23AM
09:30AM
Sep-25-22 07:00AM
Sep-23-22 09:59AM
Sep-22-22 01:22PM
Sep-21-22 02:13PM
01:49PM
07:28AM
07:00AM
Sep-20-22 08:49PM
07:45PM
Sep-19-22 05:50PM
Sep-17-22 02:45PM
11:30AM
09:53AM
Sep-16-22 01:31PM
05:43AM
Sep-15-22 12:56PM
08:34AM
Sep-14-22 02:05PM
10:37AM
Sep-13-22 05:25AM
Sep-12-22 05:50PM
06:27AM
Sep-11-22 07:03PM
06:00AM
Sep-09-22 12:20PM
06:23AM
Sep-08-22 06:28PM
04:21PM
01:11PM
09:00AM
Sep-07-22 05:09PM
Sep-06-22 05:50PM
05:00PM
Sep-05-22 03:59PM
Sep-01-22 06:51AM
Aug-31-22 05:45PM
Aug-30-22 09:54AM
Aug-29-22 09:00AM
Aug-27-22 09:36AM
09:33AM
Aug-25-22 05:45PM
Aug-24-22 12:32PM
10:23AM
Aug-23-22 03:26PM
11:28AM
09:34AM
09:00AM
Aug-22-22 11:35AM
Aug-19-22 11:30AM
03:40AM
Aug-18-22 01:24PM
11:56AM
09:45AM
Aug-16-22 05:04PM
09:43AM
Aug-15-22 09:01AM
08:45AM
Aug-14-22 10:53AM
Aug-12-22 11:16AM
10:35AM
09:22AM
08:05AM
Aug-11-22 11:00AM
10:15AM
09:00AM
07:40AM
Aug-10-22 09:46AM
Aug-09-22 07:31AM
Aug-08-22 04:20PM
08:24AM
Aug-05-22 06:00AM
Aug-04-22 04:10PM
03:01PM
Aug-03-22 05:40PM
Aug-01-22 10:15AM
10:08AM
08:05AM
Jul-31-22 07:55AM
05:57AM
Jul-29-22 11:31AM
08:40AM
Jul-28-22 11:45AM
09:44AM
Jul-27-22 05:53PM
12:12PM
08:23AM
08:00AM
07:37AM
07:10AM
06:15AM
Jul-26-22 11:45AM
08:00AM
Jul-25-22 06:25AM
Jul-22-22 03:54PM
09:16AM
09:12AM
09:04AM
Jul-21-22 03:58PM
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Meniere's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MANNING JOSEPH JEXECUTIVE VICE PRESIDENTSep 08Option Exercise44.4023,0081,021,55576,253Sep 09 05:27 PM
MANNING JOSEPH JEXECUTIVE VICE PRESIDENTSep 08Sale107.0023,0082,461,85653,245Sep 09 05:27 PM
MANNING JOSEPH JEXECUTIVE VICE PRESIDENTAug 25Option Exercise44.4023,0081,021,55580,143Aug 26 05:46 PM
Ford Robert BCHAIRMAN AND CEOAug 25Option Exercise40.24102,4254,121,871244,496Aug 26 05:49 PM
MANNING JOSEPH JEXECUTIVE VICE PRESIDENTAug 25Sale105.0326,8982,825,08853,245Aug 26 05:46 PM
Ford Robert BCHAIRMAN AND CEOAug 25Sale105.10102,42510,765,154142,071Aug 26 05:49 PM
STARKS DANIEL JDirectorJul 26Sale109.1450,0005,456,9946,923,500Jul 28 05:20 PM
Mateus FernandoSENIOR VICE PRESIDENTJul 26Sale109.052,457267,94314,503Jul 27 05:45 PM
Tyler Julie L.SENIOR VICE PRESIDENTJul 25Sale109.0925327,60033,868Jul 27 05:43 PM
WOODGRIFT RANDEL WILLIAMSENIOR VICE PRESIDENTMay 04Option Exercise44.4024,0001,065,60071,854May 05 06:12 PM
WOODGRIFT RANDEL WILLIAMSENIOR VICE PRESIDENTMay 04Sale113.0024,0002,712,10347,854May 05 06:12 PM
STARKS DANIEL JDirectorMay 03Sale113.2250,0005,661,0486,973,500May 05 05:15 PM
DALE MICHAEL DSENIOR VICE PRESIDENTMar 08Sale117.004,000468,00141,780Mar 10 05:25 PM
Earnhardt Lisa DEXECUTIVE VICE PRESIDENTMar 01Sale118.15943111,41690,630Mar 02 07:38 PM
DALE MICHAEL DSENIOR VICE PRESIDENTMar 01Sale118.151,053124,41245,780Mar 02 07:36 PM
Calamari Christopher J.SENIOR VICE PRESIDENTMar 01Sale118.1570683,41425,658Mar 02 07:33 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTMar 01Sale118.171,450171,348167,095Mar 02 07:29 PM
Ahlberg Gregory ASENIOR VICE PRESIDENTMar 01Sale118.151,099129,84733,274Mar 02 07:27 PM
WOODGRIFT RANDEL WILLIAMSENIOR VICE PRESIDENTMar 01Sale118.10964113,84949,223Mar 02 08:07 PM
Watkin JaredSENIOR VICE PRESIDENTMar 01Sale118.101,038122,58966,545Mar 02 08:02 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTMar 01Sale118.1345653,86662,172Mar 02 08:00 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTMar 01Sale118.171,550183,165112,248Mar 02 07:58 PM
Morrone Louis H.SENIOR VICE PRESIDENTMar 01Sale118.1665677,51347,278Mar 02 07:54 PM
MANNING JOSEPH JEXECUTIVE VICE PRESIDENTMar 01Sale118.1677992,04760,873Mar 02 07:51 PM
McKinstry NancyDirectorFeb 24Option Exercise29.846,280187,39433,419Feb 25 05:23 PM
McKinstry NancyDirectorFeb 24Sale116.421,614187,91031,805Feb 25 05:23 PM
Tyler Julie L.SENIOR VICE PRESIDENTFeb 22Sale119.2946255,11434,703Feb 23 08:31 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 27Option Exercise47.003,000141,00052,782Dec 28 05:41 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 27Sale142.503,000427,50049,782Dec 28 05:41 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTDec 23Option Exercise41.8155,0002,299,374158,931Dec 28 05:20 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 23Option Exercise40.3813,000525,00062,782Dec 28 05:41 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 23Sale140.0013,0001,820,00049,782Dec 28 05:41 PM
Karam SammySENIOR VICE PRESIDENTDec 23Sale140.004,700658,02318,226Dec 28 05:39 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTDec 23Sale140.0058,5018,190,140100,430Dec 28 05:20 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 17Option Exercise47.007,500352,50057,282Dec 21 05:34 PM
Morrone Louis H.SENIOR VICE PRESIDENTDec 17Option Exercise48.349,988482,82048,217Dec 21 05:38 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 17Sale137.547,5001,031,55049,782Dec 21 05:34 PM
Morrone Louis H.SENIOR VICE PRESIDENTDec 17Sale137.549,9881,373,75038,229Dec 21 05:38 PM
CAPEK JOHN MEXECUTIVE VICE PRESIDENTDec 13Option Exercise34.94149,6005,227,024470,998Dec 15 06:32 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTDec 13Option Exercise41.8155,0002,299,374158,931Dec 15 06:34 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 13Option Exercise42.5514,500617,00064,282Dec 15 06:38 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 13Sale135.0014,5001,957,50049,782Dec 15 06:38 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTDec 13Sale135.0058,4997,897,365103,931Dec 15 06:34 PM
CAPEK JOHN MEXECUTIVE VICE PRESIDENTDec 13Sale135.05149,60020,203,704321,398Dec 15 06:32 PM
Morrone Louis H.SENIOR VICE PRESIDENTDec 07Option Exercise48.349,988482,82048,217Dec 08 05:25 PM
Morrone Louis H.SENIOR VICE PRESIDENTDec 07Sale134.009,9881,338,39238,229Dec 08 05:25 PM
Morrone Louis H.SENIOR VICE PRESIDENTDec 06Option Exercise48.349,989482,86848,218Dec 08 05:25 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 06Option Exercise47.004,500211,50054,282Dec 08 05:29 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTDec 06Sale132.504,500596,25049,782Dec 08 05:29 PM
Morrone Louis H.SENIOR VICE PRESIDENTDec 06Sale131.019,9891,308,68438,229Dec 08 05:25 PM
Ahlberg Gregory ASENIOR VICE PRESIDENTNov 15Option Exercise58.1636,9352,148,12446,855Nov 17 06:11 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTNov 15Option Exercise41.8412,500523,00062,282Nov 17 06:18 PM
Ahlberg Gregory ASENIOR VICE PRESIDENTNov 15Sale130.0025,4733,311,49015,920Nov 17 06:11 PM
LANE ANDREW HEXECUTIVE VICE PRESIDENTNov 15Sale130.0110,0001,300,09076,087Nov 17 06:22 PM
Wainer Andrea FEXECUTIVE VICE PRESIDENTNov 15Sale130.0112,5001,625,11149,782Nov 17 06:18 PM
Ginascol John FEXECUTIVE VICE PRESIDENTOct 27Option Exercise47.0045,7092,148,323143,262Oct 27 06:45 PM
OSBORN WILLIAM ADirectorOct 26Option Exercise59.4215,752935,98496,996Oct 27 06:37 PM
Boudreau Philip PVICE PRESIDENTOct 25Sale126.498,0001,011,92016,876Oct 27 06:22 PM